Literature DB >> 24597507

Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy.

Howard A Crystal, Julie A Schneider, David A Bennett, Sue Leurgans, Steven R Levine1.   

Abstract

Cortical atrophy and brain vascular disease are both associated with dementia, but there are only limited pathological data on the association of brain vascular disease with cortical atrophy. We studied pathological material from the Rush Memory and Aging Project (MAP, N = 445). Cortical and hippocampal atrophy, and atherosclerosis at the circle of Willis (large vessel disease, LVD) and arteriolosclerosis (small vessel disease, SVD) were rated by neuropathologists unaware of this study's hypothesis. Quantitative measures of Alzheimer's disease (AD) pathology, specifically neuronal neurofibrillary tangles (NFT) and amyloid-beta (Aβ) burden, were also obtained. Chronic micro and macroscopic infarcts were noted. In ordinal logistic regression models that included age at death, sex, apoE genotype, statin-use, Aβ and NFT, more severe LVD was significantly associated with more severe cortical and hippocampal atrophy. The odds ratio for the association of the most severe LVD (compared to the least) with cortical atrophy was 2.7 (CI: 1.5-4.7) p = 0.001; for hippocampal atrophy the odds ratio was 2.8 (CI: 1.5-5.2), p = 0.001. The association of SVD with atrophy did not follow a consistent pattern. Neither macroscopic infarcts nor microscopic infarcts were associated with cortical or hippocampal atrophy (p's > 0.15). Tangle density was associated with cortical (p = 0.014) and hippocampal atrophy (p < 0.001). In contrast, amyloid burden was associated with less cortical (p = 0.02) or hippocampal (p = 0.002) atrophy. In this large autopsy study LVD was associated with cortical and hippocampal atrophy. The relationship between SVD and atrophy requires further study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24597507      PMCID: PMC4401460          DOI: 10.2174/1567205011666140302194358

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  20 in total

1.  Cerebrovascular disease pathology and parkinsonian signs in old age.

Authors:  Aron S Buchman; Sue E Leurgans; Sukriti Nag; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-09-01       Impact factor: 7.914

2.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

3.  The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort.

Authors:  David A Bennett; Julie A Schneider; Aron S Buchman; Carlos Mendes de Leon; Julia L Bienias; Robert S Wilson
Journal:  Neuroepidemiology       Date:  2005-08-15       Impact factor: 3.282

4.  Neuropathological basis of magnetic resonance images in aging and dementia.

Authors:  William J Jagust; Ling Zheng; Danielle J Harvey; Wendy J Mack; Harry V Vinters; Michael W Weiner; William G Ellis; Chris Zarow; Dan Mungas; Bruce R Reed; Joel H Kramer; Norbert Schuff; Charles DeCarli; Helena C Chui
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

5.  Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

Authors:  Renaud La Joie; Audrey Perrotin; Louisa Barré; Caroline Hommet; Florence Mézenge; Méziane Ibazizene; Vincent Camus; Ahmed Abbas; Brigitte Landeau; Denis Guilloteau; Vincent de La Sayette; Francis Eustache; Béatrice Desgranges; Gaël Chételat
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

6.  Relation of neuropathology to cognition in persons without cognitive impairment.

Authors:  David A Bennett; Robert S Wilson; Patricia A Boyle; Aron S Buchman; Julie A Schneider
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

7.  Age, neuropathology, and dementia.

Authors:  George M Savva; Stephen B Wharton; Paul G Ince; Gillian Forster; Fiona E Matthews; Carol Brayne
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

8.  Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Authors:  Z Arvanitakis; J A Schneider; R S Wilson; J L Bienias; J F Kelly; D A Evans; D A Bennett
Journal:  Neurology       Date:  2008-01-16       Impact factor: 9.910

9.  Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

Authors:  N C Fox; R S Black; S Gilman; M N Rossor; S G Griffith; L Jenkins; M Koller
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

10.  Cognitive reserve, presynaptic proteins and dementia in the elderly.

Authors:  W G Honer; A M Barr; K Sawada; A E Thornton; M C Morris; S E Leurgans; J A Schneider; D A Bennett
Journal:  Transl Psychiatry       Date:  2012-05-15       Impact factor: 6.222

View more
  8 in total

1.  Alzheimer's disease neuropathology may not predict functional impairment in HIV: a report of two individuals.

Authors:  Susan Morgello; Michelle Jacobs; Jacinta Murray; Desiree Byrd; Eric Neibart; Letty Mintz; Gregory Meloni; Christina Chon; John Crary
Journal:  J Neurovirol       Date:  2018-08-09       Impact factor: 2.643

Review 2.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

3.  Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population.

Authors:  Dana Godrich; Eden R Martin; Gerard Schellenberg; Margaret A Pericak-Vance; Michael Cuccaro; William K Scott; Walter Kukull; Thomas Montine; Gary W Beecham
Journal:  Alzheimers Dement       Date:  2022-02-09       Impact factor: 16.655

4.  Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals.

Authors:  Eseosa T Ighodaro; Erin L Abner; David W Fardo; Ai-Ling Lin; Yuriko Katsumata; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Janna H Neltner; Sarah E Monsell; Walter A Kukull; Debra K Moser; Frank Appiah; Adam D Bachstetter; Linda J Van Eldik; Peter T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-06       Impact factor: 6.200

Review 5.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease.

Authors:  Sara E Berman; Leonardo A Rivera-Rivera; Lindsay R Clark; Annie M Racine; Jon G Keevil; Lisa C Bratzke; Cynthia M Carlsson; Barbara B Bendlin; Howard A Rowley; Kaj Blennow; Henrik Zetterberg; Sanjay Asthana; Patrick Turski; Sterling C Johnson; Oliver Wieben
Journal:  Alzheimers Dement (Amst)       Date:  2015-12-01

7.  Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression.

Authors:  Patrick J Lao; Adam M Brickman
Journal:  Alzheimers Dement (Amst)       Date:  2018-09-22

8.  Association of carotid and intracranial stenosis with Alzheimer's disease biomarkers.

Authors:  Koung Mi Kang; Min Soo Byun; Jun Ho Lee; Dahyun Yi; Hye Jeong Choi; Eunjung Lee; Younghwa Lee; Jun-Young Lee; Yu Kyeong Kim; Bo Kyung Sohn; Chul-Ho Sohn; Dong Young Lee
Journal:  Alzheimers Res Ther       Date:  2020-09-10       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.